Upadacitinib Outcomes After Tofacitinib Failure in Patients With Moderate to Severe Ulcerative Colitis. [PDF]
ACG Case Rep JPratap K, AlBassam ABA, Narula N.
europepmc +1 more source
Treatment persistence after switching between anti-tumor necrosis factor agents and tofacitinib in ulcerative colitis: A nationwide claims-based cohort study in South Korea. [PDF]
Ther Adv GastroenterolBaek JE, Choi A, Lee HH, Lee BI, Lee KM.
europepmc +1 more source
Correction to: Incidence of active tuberculosis in Korean patients with rheumatoid arthritis: a comparison between tumor necrosis factor inhibitors and tofacitinib. [PDF]
J Rheum DisKim JY +4 more
europepmc +1 more source
Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers. [PDF]
Front Med (Lausanne)Lyu X +5 more
europepmc +1 more source
Tofacitinib demonstrates favorable efficacy but an increased risk of herpes zoster in elderly patients with rheumatoid arthritis: a retrospective cohort analysis. [PDF]
Am J Transl ResWang J, Luo Y, Wang S.
europepmc +1 more source
Liquefied Calcinosis Cutis Mimicking an Abscess in a Clinically Inactive Anti-MDA5 Antibody Positive Juvenile Dermatomyositis. [PDF]
Int J Rheum DisBhowmick K +4 more
europepmc +1 more source
Tofacitinib for polycaprolactone-induced granuloma: a case report. [PDF]
An Bras DermatolSigrist RMS +4 more
europepmc +1 more source
Aesthetic Thermotherapy-Induced Panniculitis in a Patient with Psoriasis: A Case Report. [PDF]
Clin Cosmet Investig DermatolMa X, Ying L.
europepmc +1 more source
Study of TOfacitinib for the treatment of chronic PouchITis (STOPit): a multi-centre open label induction with randomised, double blind, placebo-controlled maintenance trial. [PDF]
BMJ OpenKhoo E, Holtmann G, Begun J.
europepmc +1 more source